Literature DB >> 28615212

Conserved Vδ1 Binding Geometry in a Setting of Locus-Disparate pHLA Recognition by δ/αβ T Cell Receptors (TCRs): Insight into Recognition of HIV Peptides by TCRs.

Yi Shi1,2,3,4, Ai Kawana-Tachikawa5,6, Feng Gao1, Jianxun Qi1,2, Chuansheng Liu1,2, Jia Gao1, Hao Cheng1, Takamasa Ueno7, Aikichi Iwamoto5,6, George F Gao8,2,3,4,9.   

Abstract

Given the limited set of T cell receptor (TCR) V genes that are used to create TCRs that are reactive to different ligands, such as major histocompatibility complex (MHC) class I, MHC class II, and MHC-like proteins (for example, MIC molecules and CD1 molecules), the Vδ1 segment can be rearranged with Dδ-Jδ-Cδ or Jα-Cα segments to form classical γδTCRs or uncommon αβTCRs using a Vδ1 segment (δ/αβTCR). Here we have determined two complex structures of the δ/αβTCRs (S19-2 and TU55) bound to different locus-disparate MHC class I molecules with HIV peptides (HLA-A*2402-Nef138-10 and HLA-B*3501-Pol448-9). The overall binding modes resemble those of classical αβTCRs but display a strong tilt binding geometry of the Vδ1 domain toward the HLA α1 helix, due to a conserved extensive interaction between the CDR1δ loop and the N-terminal region of the α1 helix (mainly in position 62). The aromatic amino acids of the CDR1δ loop exploit different conformations ("aromatic ladder" or "aromatic hairpin") to accommodate distinct MHC helical scaffolds. This tolerance helps to explain how a particular TCR V region can similarly dock onto multiple MHC molecules and thus may potentially explain the nature of TCR cross-reactivity. In addition, the length of the CDR3δ loop could affect the extent of tilt binding of the Vδ1 domain, and adaptively, the pairing Vβ domains adjust their mass centers to generate differential MHC contacts, hence probably ensuring TCR specificity for a certain peptide-MHC class I (pMHC-I). Our data have provided further structural insights into the TCR recognition of classical pMHC-I molecules, unifying cross-reactivity and specificity.IMPORTANCE The specificity of αβ T cell recognition is determined by the CDR loops of the αβTCR, and the general mode of binding of αβTCRs to pMHC has been established over the last decade. Due to the intrinsic genomic structure of the TCR α/δ chain locus, some Vδ segments can rearrange with the Cα segment, forming a hybrid VδCαVβCβ TCR, the δ/αβTCR. However, the basis for the molecular recognition of such TCRs of their ligands is elusive. Here an αβTCR using the Vδ1 segment, S19-2, was isolated from an HIV-infected patient in an HLA-A*24:02-restricted manner. We then solved the crystal structures of the S19-2 TCR and another δ/αβTCR, TU55, bound to their respective ligands, revealing a conserved Vδ1 binding feature. Further binding kinetics analysis revealed that the S19-2 and TU55 TCRs bind pHLA very tightly and in a long-lasting manner. Our results illustrate the mode of binding of a TCR using the Vδ1 segment to its ligand, virus-derived pHLA.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  HIV; coevolution; human immunodeficiency virus; pHLA; recognition; δ/αβTCR

Year:  2017        PMID: 28615212      PMCID: PMC5553175          DOI: 10.1128/JVI.00725-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  TCR binding to peptide-MHC stabilizes a flexible recognition interface.

Authors:  B E Willcox; G F Gao; J R Wyer; J E Ladbury; J I Bell; B K Jakobsen; P A van der Merwe
Journal:  Immunity       Date:  1999-03       Impact factor: 31.745

Review 2.  What do TCR-pMHC crystal structures teach us about MHC restriction and alloreactivity?

Authors:  Dominique Housset; Bernard Malissen
Journal:  Trends Immunol       Date:  2003-08       Impact factor: 16.687

3.  How a single T cell receptor recognizes both self and foreign MHC.

Authors:  Leremy A Colf; Alexander J Bankovich; Nicole A Hanick; Natalie A Bowerman; Lindsay L Jones; David M Kranz; K Christopher Garcia
Journal:  Cell       Date:  2007-04-06       Impact factor: 41.582

4.  Reversed T Cell Receptor Docking on a Major Histocompatibility Class I Complex Limits Involvement in the Immune Response.

Authors:  Stephanie Gras; Jesseka Chadderton; Claudia M Del Campo; Carine Farenc; Florian Wiede; Tracy M Josephs; Xavier Y X Sng; Michiko Mirams; Katherine A Watson; Tony Tiganis; Kylie M Quinn; Jamie Rossjohn; Nicole L La Gruta
Journal:  Immunity       Date:  2016-10-04       Impact factor: 31.745

5.  An efficient and versatile mammalian viral vector system for major histocompatibility complex class I/peptide complexes.

Authors:  Ai Kawana-Tachikawa; Mariko Tomizawa; Jun-Ichi Nunoya; Tatsuo Shioda; Atsushi Kato; Emi E Nakayama; Tetsuya Nakamura; Yoshiyuki Nagai; Aikichi Iwamoto
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 6.  T cell receptor bias for MHC: co-evolution or co-receptors?

Authors:  Sneha Rangarajan; Roy A Mariuzza
Journal:  Cell Mol Life Sci       Date:  2014-03-17       Impact factor: 9.261

7.  Crystal structure of Vδ1 T cell receptor in complex with CD1d-sulfatide shows MHC-like recognition of a self-lipid by human γδ T cells.

Authors:  Adrienne M Luoma; Caitlin D Castro; Toufic Mayassi; Leslie A Bembinster; Li Bai; Damien Picard; Brian Anderson; Louise Scharf; Jennifer E Kung; Leah V Sibener; Paul B Savage; Bana Jabri; Albert Bendelac; Erin J Adams
Journal:  Immunity       Date:  2013-11-14       Impact factor: 31.745

8.  T cell receptor signaling is limited by docking geometry to peptide-major histocompatibility complex.

Authors:  Jarrett J Adams; Samanthi Narayanan; Baoyu Liu; Michael E Birnbaum; Andrew C Kruse; Natalie A Bowerman; Wei Chen; Aron M Levin; Janet M Connolly; Cheng Zhu; David M Kranz; K Christopher Garcia
Journal:  Immunity       Date:  2011-11-23       Impact factor: 31.745

9.  The molecular bases of δ/αβ T cell-mediated antigen recognition.

Authors:  Daniel G Pellicci; Adam P Uldrich; Jérôme Le Nours; Fiona Ross; Eric Chabrol; Sidonia B G Eckle; Renate de Boer; Ricky T Lim; Kirsty McPherson; Gurdyal Besra; Amy R Howell; Lorenzo Moretta; James McCluskey; Mirjam H M Heemskerk; Stephanie Gras; Jamie Rossjohn; Dale I Godfrey
Journal:  J Exp Med       Date:  2014-12-01       Impact factor: 14.307

10.  Structural interplay between germline interactions and adaptive recognition determines the bandwidth of TCR-peptide-MHC cross-reactivity.

Authors:  Jarrett J Adams; Samanthi Narayanan; Michael E Birnbaum; Sachdev S Sidhu; Sydney J Blevins; Marvin H Gee; Leah V Sibener; Brian M Baker; David M Kranz; K Christopher Garcia
Journal:  Nat Immunol       Date:  2015-11-02       Impact factor: 25.606

View more
  5 in total

1.  A humanized TCR retaining authentic specificity and affinity conferred potent anti-tumour cytotoxicity.

Authors:  Lin Chen; Ye Tian; Kai Zhan; Anan Chen; Zhiming Weng; Jiao Huang; Yanyan Li; Yongjie Sun; Hongjun Zheng; Yi Li
Journal:  Immunology       Date:  2018-05-07       Impact factor: 7.397

2.  Comparative analysis of CDR3 regions in paired human αβ CD8 T cells.

Authors:  Kun Yu; Ji Shi; Dan Lu; Qiong Yang
Journal:  FEBS Open Bio       Date:  2019-07-12       Impact factor: 2.693

3.  Divergent Peptide Presentations of HLA-A*30 Alleles Revealed by Structures With Pathogen Peptides.

Authors:  Shiyan Zhu; Kefang Liu; Yan Chai; Yanan Wu; Dan Lu; Wenling Xiao; Hao Cheng; Yingze Zhao; Chunming Ding; Jianxin Lyu; Yongliang Lou; George F Gao; William J Liu
Journal:  Front Immunol       Date:  2019-07-23       Impact factor: 7.561

4.  Isolation of a Structural Mechanism for Uncoupling T Cell Receptor Signaling from Peptide-MHC Binding.

Authors:  Leah V Sibener; Ricardo A Fernandes; Elizabeth M Kolawole; Catherine B Carbone; Fan Liu; Darren McAffee; Michael E Birnbaum; Xinbo Yang; Laura F Su; Wong Yu; Shen Dong; Marvin H Gee; Kevin M Jude; Mark M Davis; Jay T Groves; William A Goddard; James R Heath; Brian D Evavold; Ronald D Vale; K Christopher Garcia
Journal:  Cell       Date:  2018-07-26       Impact factor: 41.582

5.  Peptides of H. sapiens and P. falciparum that are predicted to bind strongly to HLA-A*24:02 and homologous to a SARS-CoV-2 peptide.

Authors:  Yekbun Adiguzel
Journal:  Acta Trop       Date:  2021-06-16       Impact factor: 3.112

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.